IL6 and metabolic dysfunction-associated steatotic liver disease: The intake of probiotics leads to reduced levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamine transferase (GGT), total cholesterol (TC), TG, and improved liver histological marker such as NAS (NAFLD Activity Score).107 Probiotic supplementation is also able to improve biomarkers of inflammation (e.g., TNF-α, IL-6) and steatosis (e.g., arginase, prolidase).109